draft banner

Team

M. Ryan Collins, CEO

Mr. Collins is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as CEO. Mr. Collins was previously the Vice-President of Finance for DAVA Pharmaceuticals. Prior to joining DAVA, Mr. Collins served as the Assistant Controller for Anda, Inc., the distribution division of Andrx Pharmaceuticals, and also previously served as a valuation consultant for Arthur Andersen LLP. Mr. Collins holds a Master's degree in Business Administration from the University of Florida.

Patrick Chu, President

Mr. Chu is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as President. Mr. Chu was previously the Director of Business Development and Associate General Counsel for DAVA Pharmaceuticals. Prior to joining DAVA, Mr. Chu worked at Wyeth and was also previously an associate at the law firm of Skadden Arps. Mr. Chu holds a law degree from Harvard Law School.

Robert O'Connor, Ph.D., Chief Scientific Officer

Dr. O'Connor is responsible for all product formulation, manufacturing and operations at Edenbridge Pharmaceuticals. Prior to joining Edenbridge, Dr. O'Connor was Vice President, Product Development & Technical Services, at Norwich Pharmaceuticals. Dr. O'Connor was also previously World Wide Vice President, Technical Operations, for Cordis, a Johnson and Johnson Company. Dr. O'Connor received his Ph.D. in pharmaceutics from the University of the Sciences in Philadelphia (Philadelphia College of Pharmacy & Science).

Peter M. Licata, CPA, Chief Financial Officer

Mr. Licata is responsible for all accounting and finance related functions at Edenbridge Pharmaceuticals. Prior to joining the Company, Mr. Licata was the Senior Vice President of Finance at Rising Pharmaceuticals. Mr. Licata holds a bachelor's degree in accounting from the State University of New York at New Paltz and is a licensed CPA in the State of New York.

William Reilly, Jr., Vice President, Product Development

Mr. Reilly is responsible for product development, scale up and transfer of all products originating from Edenbridge Pharmaceuticals' R&D laboratory. Prior to joining Edenbridge, Mr. Reilly was Director of Product Development and Technical Services at Lannett Company. Mr. Reilly was also previously a Managing Consultant at Tunnell Consulting, a pharmaceutical focused consultancy. Mr. Reilly received his pharmacy degree from the University of the Sciences in Philadelphia (Philadelphia College of Pharmacy) and an MBA from Fairleigh Dickinson University.

Jing Li, Ph.D., Vice President, Analytical R&D

Dr. Li oversees all analytical development activities for Edenbridge Pharmaceuticals and also provides analytical CMC support for product development and commercial manufacturing activities. Prior to joining Edenbridge, Dr. Li served as Director of Analytical Services at Frontage Laboratories and Associate Director of Analytical Research and Development at Endo Pharmaceuticals. Dr. Li received his Ph.D. in Chemistry from Brandeis University.